We’ve compiled a list of Larry Robbins’ Long-Term Stock Picks and now, let’s see how DXC Technology Company (NYSE:DXC) compares to the other picks.
Larry Robbins is a hedge fund manager and the brain behind Glenview Capital, a top investment firm in New York. He’s known for his analytical skills, especially in healthcare investing. Born in 1983 in New Jersey, he developed a passion for math early on. His education at the Wharton School of the University of Pennsylvania laid the groundwork for his finance career.
Before starting Glenview Capital in 2000, Robbins managed portfolios at Omega Advisors. His firm quickly gained recognition for its success, focusing on thorough research and industries like healthcare, tech, and consumer goods. Glenview’s published returns have often exceeded 20% in some years. As of late 2024, it manages around $5.7 billion in investments, with a knack for spotting undervalued healthcare stocks.
To analyze stock picks, we reviewed Glenview’s 13F portfolio from the end of the third quarter of 2024. We only included companies that have consistently appeared in the portfolio over the past three years. Notably, it’s often beneficial to track hedge fund favorites, as this strategy has historically outperformed the market. Our quarterly newsletter has seen a return of 275% since 2014, significantly beating its benchmark.
DXC Technology Company (NYSE:DXC) is a global IT services and consulting firm based in Ashburn, Virginia. This organization is drawing interest for several strong reasons. Their fiscal year 2024 report highlights solid financial health, showing operating cash flow of $1.36 billion and free cash flow exceeding $750 million for the third year in a row. This trend signals effective cash management and opens doors for investments or paying down debt.
Additionally, DXC has teamed up with Ferrari to enhance the infotainment systems of their vehicles, strengthening their partnership. They’ve also expanded a strategic alliance with ServiceNow to drive AI innovations across businesses. This initiative includes creating a Center of Excellence aimed at implementing AI solutions more efficiently for clients.
DXC ranks 5th on our list of Larry Robbins’ long-term stock selections. While we see potential in DXC, there may be other stocks that could offer even higher returns in a shorter time. For instance, if you’re looking for stocks priced under five times earnings that have even more promise, that’s worth exploring further.
READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap
Disclosure: None. This article was originally posted on Insider Monkey.
Check out this related article: Revolutionizing Battery Production: How Rimac Technology Leverages iTAC.MOM.Suite for Sustainable Manufacturing
Source linkLarry Robbins, Glenview Capital, hedge fund manager, DXC, investment strategies, portfolio manager, Stock Picks, healthcare sector
